The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...

The agreement announced Wednesday includes sweeping changes to the Cigna PBM’s business practices, including no longer ...

Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...

Express Scripts, a pharmacy benefit manager and subsidiary of Cigna (CI), has reached a settlement with the FTC over ...

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.

According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...

The settlement comes after the FTC in September 2024 brought action against three prescription drug benefit managers, including Express Scripts, alleging the companies were artificially inflating the ...